Cargando…
Enrichment of TP53 alterations within GCB-like DNA subclassifications of diffuse large B-cell lymphoma after transition from de-novo to relapsed or refractory disease
Autores principales: | Lund, Shelby, Ngisa, Valentine, Weber, Kennedee, Rutz, Alison, Guidinger, Jinda, Hartert, Keenan Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242832/ https://www.ncbi.nlm.nih.gov/pubmed/35551110 http://dx.doi.org/10.5045/br.2022.2022052 |
Ejemplares similares
-
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker
por: Batlle-López, Ana, et al.
Publicado: (2016) -
Chinese Ischemic Stroke Subclassification
por: Gao, S., et al.
Publicado: (2011) -
The Evolution of Ovarian Carcinoma Subclassification
por: Köbel, Martin, et al.
Publicado: (2022) -
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy
por: Ferraro, Francesca, et al.
Publicado: (2022) -
A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas
por: van der Meeren, L. E., et al.
Publicado: (2019)